Is physician adherence to prescription guidelines a general trait of health care practices or dependent on drug type? - A multilevel logistic regression analysis in South Sweden

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 8, 2009, Pages 682-690

  Ohlsson, Henrik ^a,b   Merlo, Juan ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b Division of Social Medicine   (Sweden)

Author keywords

Decision making; Guideline adherence; Inequality; Multilevel models; Therapeutic traditions

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTON PUMP INHIBITOR; SIMVASTATIN; ANGIOTENSIN RECEPTOR ANTAGONIST;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG USE; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PHARMACEUTICAL CARE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROBABILITY; PROFESSIONAL PRACTICE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STATISTICAL MODEL; SWEDEN; ATTITUDE TO HEALTH; CLINICAL PRACTICE; HEALTH PERSONNEL ATTITUDE; MIDDLE AGED; REGISTER; STATISTICAL ANALYSIS; STATISTICS;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATTITUDE OF HEALTH PERSONNEL; DRUG PRESCRIPTIONS; FEMALE; GUIDELINE ADHERENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTILEVEL ANALYSIS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PROTON PUMP INHIBITORS; REGISTRIES; SWEDEN;

EID: 70349773822     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1767     Document Type: Article

References (26)

1. Davis P, Gribben B. Rational prescribing and interparctitioner variation. A multilevel approach. Int J Technol Assess Health Care 1995; 11(3): 428-442.
2. Davis P, Gribben B, Lay-Yee R, et al. How much variation in clinical activity is there between general practitioners? A multi-level analysis of decision-making in primary care. J Health Serv Res Policy 2002; 7(4): 202-208.
3. Ohlsson H, Lindblad U, Lithman T, et al. Understanding adherence to official guidelines on statin prescribing in primary health care-a multi-level methodological approach. Europ J Clin Pharmacol 2005; 61(9): 657-665.
4. Ohlsson H, Merlo J. Understanding the effects of a decentralized budget on physicians compliance with guidelines for statin prescription; a multilevel methodological approach. BMC Health Serv Res2007; 7: 68 (8 May 2007).
5. Brookhart MA, Solomon DH, Wang P, et al. Explained variation in a model of therapeutic decision making is partitioned across patient, physician, and clinic factors. J Clin Epidemiol 2006; 59(1): 18-25. (Pubitemid 41797471)
6. Ohlsson H, Chaix B, Merlo J. Therapeutic traditions, patient socioeconomic characteristics and physicians' early new drug prescribing - a multilevel analysis of rosuvastatin prescription in South Sweden. Eur J Clin Pharmacol 2009; 65(2): 141-150.
7. Ohlsson H, Lynch K, Merlo J. Is physicianś adherence to prescription guidelines associated with patient socio-economic status?-An analysis of statin prescriptions in South Sweden. In Press (Journal of Epidemiology and Community Health) 2009.
8. Goldstein H. Multilevel Statistical Models (3rd edn), Hodder Arnold: London, UK, 2003.
9. WHO. About the ATC/DDD system (http://www.whocc.no/atcddd/)
10. Läkemedelsrådet, editor, Bakgrundsmaterial (Backgroundmaterial) [in Swedish] Lund, 2006.
11. Läkemedelsrådet, editor, Skånelistan 2006 [in Swedish] Lund, 2006.
12. Chaix B, Rosvall M, Merlo J. Assessment of the magnitude of geographical variations and socioeconomic contextual effects on ischemic heart disease mortality: a multilevel survival analysis of a large Swedish cohort. J Epidemiol Comm Health 2007; 61(4): 349-355. (Pubitemid 46494017)
13. WorldBank. Country Classification [http://www. worldbank. org/data/ countryclass/countryclass. html] 2005.
14. Regions SAoLAa, editor Swedish Health.Care in an International Context Stockholm, 2005.
15. Snijders T, Bokser R. Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling. Sage Publications: Thousand Oaks, California, 1999.
16. Goldstein H, Browne W, Rasbash J. Partitioning variation in generalised linear multilevel models. Understanding Statistics 2002; 1: 223-232.
17. Wamala SP, Mittleman MA, Schenck-Gustafsson K, et al. Potential explanations for the educational gradient in coronary heart disease: a population-based case-control study of Swedish women. Am J Public Health 1999; 89(3): 315-321. (Pubitemid 29282762)
18. Larsen K, Merlo J. Appropriate assessment of neighbourhood effects on individual health: integrating random and fixed effects in multilevel logistic regression. Am J Epidemiol 2005; 161(1): 81-88. (Pubitemid 40053282)
19. Larsen K, Petersen JH, Budtz-Jorgensen E, et al. Interpreting parameters in the logistic regression model with random effects. Biometrics 2000; 56(3): 909-914. (Pubitemid 30672584)
20. Browne W. MCMC Estimation in MLwiN (Version 2.0). Institute of Education University of London: London, 2003.
21. Rasbash J, Steele F, BrowneW. A User's Guide to MLwiN, Version 2.0. Documentation Version 2. Centre for Multilevel Modelling, Institute of Education, University of London: London, UK, 2003.
22. Spiegelhalter D, Best N, Carlin B, et al. Bayesian measures of model complexity and t. J R Statist SocB 2002; 64: (Part 4): 583-639.
23. Landon BE, Reschovsky J, Reed M, et al. Personal, organizational, and market level influences on physicians' practice patterns: results of a national survey of primary care physicians. Med Care 2001; 39(8): 889-905. (Pubitemid 33686270)
24. O'Neill L, Kuder J. Explaining variation in physician practice patterns and their propensities to recommend services. Med Care Res Rev 2005; 62(3): 339-357. (Pubitemid 40664430)
25. Wennberg JE. Wrestling with variation: an interview with Jack Wennberg [interviewed by Fitzhugh Mullan]. Health Aff (Millwood) 2004; 10(Suppl Web Exclusive):VAR 73-80.
26. Wennberg JE, Barnes BA, Zubkoff M. Professional uncertainty and the problem of supplier-induced demand. Soc Sci Med 1982; 16(7): 811-824. (Pubitemid 12059538)